speaking of wellness

mRNA: A Safe Shot

By John Swartzberg, MD, Chair, Wellness Letter Editorial Board

In a move we didn’t really see coming given the current administration’s attitude toward vaccines, the FDA approved the first mRNA flu vaccine, mFLUVISA, manufactured by Moderna, in early August. It’s presently authorized for people ages 50 to 64 and was given accelerated approval for those...